Connection
J. Steven Leeder to Immunosuppressive Agents
This is a "connection" page, showing publications J. Steven Leeder has written about Immunosuppressive Agents.
|
|
Connection Strength |
|
![](https://researchers.childrensmercy.org/Framework/Images/connection_left.gif) |
|
![](https://researchers.childrensmercy.org/Framework/Images/connection_right.gif) |
|
0.243 |
|
|
|
-
Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee IA. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Clin Pharmacol Ther. 2015 Jul; 98(1):19-24.
Score: 0.126
-
Lalan S, Abdel-Rahman S, Gaedigk A, Leeder JS, Warady BA, Dai H, Blowey D. Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population. Pediatr Nephrol. 2014 Oct; 29(10):2039-49.
Score: 0.117
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|